HTGC - Hercules Capital, Inc.

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 17.42

Open

$ 16.95

Bid

$ 17.25 x 25

Ask

$ 17.53 x 6

Day's Range

$ 16.95 - $ 17.45

52 Week Range

$ 14.87 - $ 20.48

Volume

1,376,495

Average Volume

Market Cap

3.16B

Beta (5Y Monthly)

$ 0.86

PE Ratio (TTM)

$ 4.87

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.11)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-13-2025	12-31-2024	10-K
4	10-30-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	02-15-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	02-16-2023	12-31-2022	10-K
12	11-02-2022	09-30-2022	10-Q
13	07-28-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-22-2022	12-31-2021	10-K
16	10-28-2021	09-30-2021	10-Q
17	07-29-2021	06-30-2021	10-Q
18	04-29-2021	03-31-2021	10-Q
19	02-23-2021	12-31-2020	10-K
20	10-29-2020	09-30-2020	10-Q
21	07-30-2020	06-30-2020	10-Q
22	05-04-2020	03-31-2020	10-Q
23	02-20-2020	12-31-2019	10-K
24	10-30-2019	09-30-2019	10-Q
25	08-01-2019	06-30-2019	10-Q
26	05-02-2019	03-31-2019	10-Q
27	02-21-2019	12-31-2018	10-K
28	11-01-2018	09-30-2018	10-Q
29	08-02-2018	06-30-2018	10-Q
30	05-03-2018	03-31-2018	10-Q
31	02-22-2018	12-31-2017	10-K
32	11-02-2017	09-30-2017	10-Q
33	08-03-2017	06-30-2017	10-Q
34	05-04-2017	03-31-2017	10-Q
35	02-23-2017	12-31-2016	10-K
36	11-03-2016	09-30-2016	10-Q
37	08-04-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	02-25-2016	12-31-2015	10-K
40	11-05-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

UBS Maintains Neutral on Hercules Capital,...
10/14/2025 16:30:33

UBS analyst Vilas Abraham maintains Hercules Capital (NYSE:HTGC) with a Neutral and lowers the price target from $19 to $18.5.

Piper Sandler Maintains Overweight on Herc...
10/09/2025 13:57:37

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:HTGC) with a Overweight and lowers the price target from...

uniqure-stock-doubles-on-promising-data-from-huntingtons-disease-trial

uniQure Stock Doubles On Promising Data Fr...
09/24/2025 14:23:24

UniQure's AMT-130 gene therapy slowed Huntington's disease progression in a Phase 1/2 trial, supported by new $175 mill...

uniQure Refinances $50M Debt And Gains Acc...
09/24/2025 11:12:18

Term of current $50 million debt outstanding extended from January 2027 to October 2030Additional $100 million available subjec...

Senseonics Holdings Memorandum Of Understa...
09/03/2025 21:22:00

CGM commercial operations to transition from Ascensia Diabetes Care to SenseonicsBrian Hansen to be appointed Chief Commercial ...

JMP Securities Maintains Market Outperform...
08/04/2025 11:58:38

JMP Securities analyst Devin Ryan maintains Hercules Capital (NYSE:HTGC) with a Market Outperform and raises the price targe...

Piper Sandler Maintains Overweight on Herc...
08/01/2025 12:17:15

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:HTGC) with a Overweight and raises the price target from...

Hercules Capital Q2 NII $0.50 Beats $0.47 ...
07/31/2025 20:14:38

Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

UBS Maintains Neutral on Hercules Capital,...
07/16/2025 15:26:14

UBS analyst Vilas Abraham maintains Hercules Capital (NYSE:HTGC) with a Neutral and raises the price target from $18.5 to $19.

recent-report-shows-that-rep-virginia-foxx-sold-up-to-65k-worth-of-energy-transfer-stock

Recent Report Shows That Rep. Virginia Fox...
07/04/2025 15:00:18

Dyne Therapeutics Enters $275M Debt Financ...
06/30/2025 20:03:15

mercks-dealmaking-intensifies-with-moonlake-bid-as-keytruda-patent-cliff-nears-report

Merck's Dealmaking Intensifies With MoonLa...
06/03/2025 11:38:09

Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it face...

Hercules Capital Q1 EPS $0.45 Misses $0.47...
05/01/2025 20:23:46

Hercules Capital (NYSE:HTGC) reported quarterly earnings of $0.45 per share which missed the analyst consensus estimate of $0.4...

Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37

Wells Fargo Maintains Overweight on Hercul...
04/28/2025 14:05:09

Wells Fargo analyst Finian O'Shea maintains Hercules Capital (NYSE:HTGC) with a Overweight and lowers the price target f...

UBS Maintains Neutral on Hercules Capital,...
04/17/2025 18:19:36

UBS analyst Vilas Abraham maintains Hercules Capital (NYSE:HTGC) with a Neutral and lowers the price target from $20 to $18.

What Analysts Are Saying About Hercules Ca...
04/08/2025 18:00:43

Keefe, Bruyette & Woods Maintains Outperfo...
04/08/2025 16:12:00

Keefe, Bruyette & Woods analyst Paul Johnson maintains Hercules Capital (NYSE:HTGC) with a Outperform and lowers the pri...

Piper Sandler Maintains Overweight on Herc...
04/08/2025 13:15:05

Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:HTGC) with a Overweight and lowers the price target from...